Bausch Health Companies

Synergetics USA, Inc. is a medical device company based in O'Fallon, Missouri, specializing in the manufacture and distribution of precision surgical devices and equipment primarily for the ophthalmology and neurosurgery markets. The company offers approximately 1,000 catalog items, including precision-engineered disposable and reusable devices, surgical equipment, and procedural kits. Its product lines feature a variety of energy modalities such as laser, ultrasonic, radio frequency, and visible light energy for surgical procedures. Notable offerings include the VersaVIT 2.0 vitrectomy system, procedural packs under the VersaPACK and Core Essentials brands, fiberoptic endoilluminators, endolaser probes, and illumination equipment branded as Photon. Synergetics USA distributes its products directly as well as through distributors and independent sales representatives to hospitals, ambulatory surgery centers, and surgeons' offices. The company has been operational since 1991 and has established itself as a key player in the vitreoretinal surgical market.

Sprout Pharmaceuticals, Inc. is a medical company focused on developing products for female sexual health, specifically addressing female sexual dysfunction. Founded in 2011 and headquartered in Raleigh, North Carolina, the company is known for its flagship product, Addyi, a non-hormonal pill designed to treat acquired and generalized hypoactive sexual desire disorder in premenopausal women. By providing treatment options for women experiencing low libido, Sprout Pharmaceuticals aims to alleviate distress related to this condition and enhance the overall quality of their sexual experiences.

Amoun Pharmaceutical Company S.A.E. is a prominent Egyptian firm specializing in the development, manufacturing, marketing, and distribution of a diverse array of human pharmaceuticals and animal health products. Founded in 1998 and headquartered in Cairo, the company not only serves the domestic market but also exports its products to approximately 28 countries across the Middle East, Africa, Asia, and Europe. Amoun's extensive product portfolio includes various therapeutic areas, such as anesthesia, respiratory conditions, urinary disorders, and gastrointestinal health. The company is committed to addressing unmet therapeutic needs, with over 30 new products in various stages of registration aimed at tackling high-prevalence diseases of national interest. Amoun's robust product pipeline and ongoing expansions are central to its growth strategy, ensuring a sustained contribution to healthcare and enhanced value for stakeholders.

Salix Pharmaceuticals, Ltd. is a specialty pharmaceutical company focused on the development and commercialization of prescription drugs for gastrointestinal diseases in the United States. Founded in 1989 and headquartered in Raleigh, North Carolina, the company offers a range of products, including Xifaxan for hepatic encephalopathy and traveler's diarrhea, Apriso for ulcerative colitis, and Moviprep for colon cleansing prior to colonoscopy. Salix’s portfolio also includes treatments for opioid-induced constipation, fecal incontinence, and various gastrointestinal conditions such as gastroesophageal reflux disease and hypertriglyceridemia. Additionally, the company provides products for managing symptoms related to HIV/AIDS treatments and renal transplantation. Salix Pharmaceuticals has been dedicated to delivering effective solutions for healthcare providers and patients in the realm of gastroenterology for over two decades. As of April 2015, it operates as a subsidiary of Valeant Pharmaceuticals International.

Dendreon is a Seattle-based biotechnology company dedicated to transforming cancer treatment through the discovery, development, and commercialization of innovative therapeutics. The company specializes in Active Cellular Immunotherapy (ACI), utilizing its expertise in antigen identification, engineering, and cell processing to create product candidates that aim to stimulate the immune system's response to cancer. ACI has the potential to provide significant clinical benefits, such as increased survival rates, while minimizing toxicity. In addition to its ACI offerings, Dendreon is also developing an orally-available small molecule that targets TRPM8, which may have applications in various cancer types as well as benign prostatic hyperplasia. The company focuses on reprogramming the body's immune cells to recognize and attack cancer cells, thereby improving patient outcomes with a reduced impact on healthy tissues.

Valeo Medical, Inc., a life sciences company, develops a non-invasive diagnostic blood test for endometriosis. The company was founded in 2003 and is based in Burlington, Massachusetts. Valeo raised money as part of the Discovery Life Sciences fund which was partly funded by the Nashville Capital Network.

PreCision Dermatology is a rapidly growing company dedicated to advancing skincare through innovative therapies. It focuses on developing products that enhance the delivery of active ingredients to the skin, reducing side effects and strengthening the skin's natural barrier. The company's portfolio addresses various dermatological conditions like atopic dermatitis, acne, and rosacea. PreCision Dermatology expands its offerings through internal research, acquisitions, licensing agreements, and strategic partnerships.

Solta Medical, Inc. is a medical device company specializing in energy-based systems for aesthetic applications. Founded in 1995 and headquartered in Hayward, California, the company designs, develops, and manufactures a range of products for skin rejuvenation and body contouring. Notable offerings include the Thermage NXT system, which provides non-invasive skin tightening and cellulite enhancement, as well as the Fraxel re:fine, re:store, and re:pair systems, which address various skin conditions such as fine lines, pigmentation, acne scars, and deeper wrinkles. These systems comprise handpieces, a user-friendly console, an energy source, and disposable treatment tips. Solta Medical serves a diverse clientele, including dermatologists, plastic surgeons, and gynecologists, and distributes its products through a direct sales force and a network of distributors both in the United States and internationally. The company was previously known as Thermage, Inc. before rebranding to Solta Medical in January 2009.

Bausch + Lomb is a prominent global eye health business dedicated to enhancing and protecting vision for people at all life stages. With a comprehensive portfolio exceeding 400 products, the company offers a wide range of solutions, including contact lenses, lens care products, eye care products, ophthalmic pharmaceuticals, and surgical devices. It operates in three primary segments: vision care, surgical, and ophthalmic pharmaceuticals. The vision care segment includes contact lenses, where the company holds a notable market share, as well as ocular health products such as Biotrue and Lumify. The surgical segment provides essential tools and technologies for cataract and vitreoretinal surgeries, including intraocular lenses and surgical instruments. Additionally, the ophthalmic pharmaceuticals segment features a variety of treatments for eye conditions, including products like Xipere, Vyzulta, and Lotemax. Bausch + Lomb's commitment to eye health underscores its mission to serve millions globally.

Obagi Medical Products, Inc. is a specialty pharmaceutical company established in 1988 and headquartered in Irvine, California. The company focuses on developing, marketing, and selling topical aesthetic and therapeutic prescription skin care systems. Its product offerings include the Obagi Nu-Derm System, which addresses various skin concerns such as fine lines, wrinkles, acne, and hyperpigmentation, as well as other systems like the Obagi-C Rx System and Professional-C products that incorporate Vitamin C. Additionally, Obagi provides solutions for specific issues including the ELASTIderm Eye and Décolletage for skin elasticity, CLENZIderm M.D. Systems for acne treatment, and the Obagi Rosaclear System for rosacea. The company markets its products through a direct sales force and distribution partners, targeting dermatologists, plastic surgeons, and other medical professionals focused on aesthetic and therapeutic skin care.

Medicis Pharmaceutical is a pharmaceutical and medical product development company that specializes in the creation, manufacturing, and sale of a diverse range of products. The company focuses primarily on areas such as gastroenterology, neurology, and dermatology, particularly in the treatment of dermatological and aesthetic conditions. Its offerings include prescription products designed to address various skin-related issues, including acne, fungal infections, psoriasis, rosacea, seborrheic dermatitis, and skin-structure infections. Through its innovative approach, Medicis Pharmaceutical aims to meet the healthcare needs of patients worldwide.

Eyetech Pharmaceuticals, established as a biopharmaceutical company, focused on developing novel therapeutics for eye diseases. Its primary achievement was pioneering research into wet age-related macular degeneration, a significant advancement in the field. In 2012, Valeant Pharmaceuticals International acquired Eyetech for $22 million.

Probiótica Laboratórios Ltda., founded in 1986 and based in Matão, Brazil, specializes in the development, manufacture, and sale of food supplements, primarily catering to the sports nutrition market. The company's product range includes amino acids, protein bars, BCAAs, proteins, and various health and beauty supplements, as well as energy-boosting and thermogenic options. Probiótica's offerings are available for purchase online, and the company operates as a subsidiary of Supley Laboratório de Alimentos e Suplementos Nutricionais Ltda.

iNova Pharmaceuticals is a healthcare company specializing in the development and marketing of over-the-counter and prescription medications. Based in Australia and New Zealand, its product portfolio spans various therapeutic areas such as weight management, pain relief, dermatology, cardiology, respiratory health, allergy, and women's health. The company aims to enhance human health and well-being by providing high-quality pharmaceutical products and services to patients and consumers.

Dermik Laboratories offers therapeutic products to treat acne, actinic keratosis, dermatitis and eczema, insect bites and stings, plant rashes, psoriasis, rosacea, and rough skin; aesthetic products, including HIV facial lipoatrophy products, chemical peels for revitalizing, and skin hydration products; and podiatric products for nail fungus.

PharmaSwiss SA develops and manufactures generics and over-the-counter pharmaceutical products.

Aton Pharma, Inc., established in 2001 and headquartered in Lawrenceville, New Jersey, operates as a specialty pharmaceutical company. Its primary focus is on treating ophthalmic diseases, orphan conditions, and acute care hospital products. The company's product portfolio includes treatments for metabolic, neurological, cardiovascular diseases, and under-treated conditions such as dry eye. One of its key products is timolol maleate ophthalmic gel forming solution for managing elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma. Aton Pharma serves patients, caregivers, and healthcare professionals across the United States, Asia Pacific region, Australia, and internationally. Prior to operating independently, it was a subsidiary of Merck & Co., Inc.

Private Formula International is a privately owned medium sized Australian company. It owns and distributes the Dr LeWinns brand through department stores and pharmacies nationally as well as internationally. With 50+ staff based in Australia, the company is a leading innovator of anti-ageing skincare products and treatments providing its consumers with quality products that work at an accessible price point. Private Formula International head office is located at 460 Bay Street, Port Melbourne, Victoria. The company outsources its manufacturing activities through 3 overseas and 4 local suppliers. Private Formula has always been mindful of the potential impact on waste disposals in general and has been concerned on how the global environment changes could impact the future. Private Formula has recently being made aware of a structured organization in this area ie. National Packaging Covenant and fully supports its principles and goals hence, the company is now a signatory of the organization.

Tecnofarma is a Mexican pharmaceutical manufacturer specializing in the production of generic interchangeable medications (GI). Its product portfolio caters primarily to government institutions such as IMSS and ISSSTE, along with private sector clients like department stores. Tecnofarma also offers its own line of branded drugs, focusing on therapeutic areas including rheumatology, endocrinology, and cardiology.

Dow Pharmaceutical Sciences, Inc. engages in the development of topical drug products for pharmaceutical and biotechnology clients.

DermTech, Inc. is a molecular diagnostic company based in La Jolla, California, focused on developing and marketing innovative non-invasive diagnostic tests for skin cancer and related conditions. The company’s flagship product, the Pigmented Lesion Assay (PLA), is a gene expression test designed to rule out melanoma and eliminate the need for surgical biopsies of atypical pigmented lesions. Additionally, DermTech offers the Nevome test, which serves as an adjunctive reflex test for the PLA, along with adhesive skin sample collection kits and gene expression assays targeting various inflammatory pathways. The company is also working on diagnostic products for non-melanoma skin cancer and risk assessment. DermTech primarily markets its products to pathology and oncology practitioners, leveraging advanced qPCR assays that utilize non-invasive adhesive tape biopsy methods to analyze RNA expression levels in skin samples.

DermaTech Pty Ltd is an Australian company specializing in the development, production and distribution of innovative products to address common dermatological conditions such as dry, itchy or sensitive skin, acne, eczema, psoriasis, contact dermatitis, insect bites, skin warts and sunburn.

Coria Laboratories, Ltd. is a privately held pharmaceutical company based in Fort Worth, Texas, specializing in research, development and marketing of branded prescription and over-the-counter dermatology products. The company also provides products for dermatomes, atopic dermatitis, seborrheic dermatitis, contact dermatitis, acne, hyperkeratotic skin disorders, ichthyosis, psoriasis, and keratosis pilaris.

Xcel Pharmaceuticals are a specialty pharmaceutical company focused on prescription products that treat disorders of the central nervous system (CNS). They currently focus on neurology, a segment of the CNS market where a limited number of high-prescribing physicians write a significant number of the prescriptions for neurology products. Their product portfolio consists of four commercial products and two product candidates. Their commercial products include two epilepsy products, Diastat® and Mysoline®, and two migraine products, Migranal® and D.H.E. 45®. Their product candidates include MT 300™, a potential treatment for migraine, and retigabine, a potential treatment for epilepsy. their nationwide field sales organization promotes their products to high-prescribing epilepsy and migraine specialists. Their strategy is to increase prescription demand for Their lead products through targeted sales and marketing efforts, to successfully develop and commercialize Their late-stage development product candidates, to leverage Their CNS presence through the acquisition of additional late-stage development product candidates and commercial products, and to develop enhancements for Their current products. Their corporate infrastructure is designed to support Their field sales organization, to manage Their product development efforts, to identify and pursue the acquisition of additional late-stage development product candidates and commercial products, and to manage Their product enhancement efforts. They have developed valuable relationships with experts and third-party consultants that They intend to utilize for the advancement of late-stage development product candidates, including retigabine, through the development and regulatory approval process. They also utilize third parties to manufacture and distribute Their products and to support Their product development and enhancement efforts.

A leading global eye health organization that is solely focused on protecting, enhancing and restoring people’s eyesight.